SCHEMBL77699

SCHEMBL77699

CP(=O)(O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25797420 1.00
Phosphoramidic Acid SCHEMBL15770228 0.88 CA2 (0.50)
Methyl Phosphonate SCHEMBL641731 0.86 CA2 (0.73)
Methyl Phosphonate SCHEMBL7116871 0.86 CA2 (0.73)
Methyl Phosphonate SCHEMBL641732 0.79 CA2 (0.61)
SCHEMBL102311 0.78
SCHEMBL2407345 0.78 CA2 (0.46)
SCHEMBL1118893 0.78
SCHEMBL7820 0.78
SCHEMBL25522 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 885 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595481-B2 Methods and compositions for neuroprotection DISARM THERAPEUTICS, INC. (US) 2026-04-07 US claimed
US-20230242909-A1 METHODS AND COMPOSITIONS FOR NEUROPROTECTION DISARM THERAPEUTICS, INC. 2023-08-03 US claimed
CN-115176002-A Methods and compositions for neuroprotection 达萨玛治疗公司 2022-10-11 CN claimed
EP-4065714-A1 METHODS AND COMPOSITIONS FOR NEUROPROTECTION Disarm Therapeutics, Inc. (US) 2022-10-05 EP claimed
WO-2021108602-A1 METHODS AND COMPOSITIONS FOR NEUROPROTECTION DISARM THERAPEUTICS, INC. (US) 2021-06-03 WO claimed
CN-112180007-A Metabolics-based diagnostic marker for generalized pustular psoriasis and application thereof 上海市皮肤病医院 2021-01-05 CN claimed
CN-111440796-A Improved exon skipping compositions for the treatment of muscular dystrophy 萨雷普塔医疗公司 2020-07-24 CN claimed
EP-3476474-B1 REACTIVE SORBENT BASED ON ACTIVATED CLAY FOR DECONTAMINATING CHEMICAL WARFARE AGENT (CWA) AND DECONTAMINATION METHOD USING THE SAME AGENCY DEFENSE DEV (KR) 2020-06-03 EP claimed
US-10260071-B2 CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity COLEY PHARMACEUTICAL GMBH (DE) 2019-04-16 US claimed
US-20160348115-A1 CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity PFIZER INC. 2016-12-01 US claimed
WO-1997010254-A1 OLIGOMERS WHICH INHIBIT EXPRESSION OF COLLAGEN GENES GUNTAKA RAMAREDDY V (US) 1997-03-20 WO claimed
US-5578716-A DNA methyltransferase antisense oligonucleotides MCGILL UNIVERSITY (CA) 1996-11-26 US claimed
EP-0731835-A1 ANTISENSE OLIGONUCLEOTIDES HAVING TUMORIGENICITY-INHIBITING ACTIVITY HYBRIDON, Inc. (US) 1996-09-18 EP claimed
EP-0711343-A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION HYBRIDON, Inc. (US) 1996-05-15 EP claimed
WO-1995018137-A1 IMPROVED PROCESS FOR THE PURIFICATION OF OLIGOMERS GENTA INCORPORATED (US) 1995-07-06 WO claimed
WO-1995015378-A1 ANTISENSE OLIGONUCLEOTIDES HAVING TUMORIGENICITY-INHIBITING ACTIVITY HYBRIDON, INC. (US) 1995-06-08 WO claimed
WO-1995004142-A2 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION HYBRIDON, INC. (US) 1995-02-09 WO claimed
EP-0022141-B2 COMPOSITIONS AND METHODS FOR REDUCING HERBICIDAL INJURY MONSANTO COMPANY (US) 1987-12-02 EP claimed
EP-0022141-B1 COMPOSITIONS AND METHODS FOR REDUCING HERBICIDAL INJURY MONSANTO COMPANY (US) 1983-06-08 EP claimed
US-4048022-A Simulant compound and method for testing an agent alarm THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1977-09-13 US claimed